Medical language changes when our understanding of a condition changes. Sometimes, even a familiar name deserves a second look.
That question will be explored at the International Conclave of The Association of Tamil Nadu Members of RCOG. Dr. S. Vyjayanthi, Director & Consultant Fertility Specialist at MotherToBe Fertility Centre & Academy, will contribute to the session “PCOS / PMOS – What Is in a Name?”
Taking place at Anna Salai, Chennai, on 19 September 2026, the conclave is built around the theme “Rethink | Rewire | Rewrite” and brings specialists together for academic exchange.
For Dr. Vyjayanthi, the subject is closely connected to her everyday field of work. Her clinical and professional interests span reproductive medicine, fertility care, PCOS and reproductive surgery.
PCOS / PMOS – Why the Name Is Part of the Conversation
Polycystic Ovary Syndrome, commonly known as PCOS, is associated with a range of reproductive, hormonal and metabolic features. Yet the term itself has increasingly become part of professional discussion about how accurately the name reflects the broader nature of the condition.
That makes “PCOS / PMOS – What Is in a Name?” a thought-provoking topic for an international professional forum. The discussion provides an opportunity to look beyond terminology and consider how the way a condition is described can influence clinical understanding, patient communication and the wider conversation around women’s health.
The session is therefore about more than replacing one term with another. At its heart is a practical question: does the name accurately describe the condition clinicians are seeing and patients are living with?
For patients seeking information about the condition and its relationship with fertility, MotherToBe provides a dedicated resource on PCOS treatment and fertility care in Hyderabad.
The Topic: PCOS / PMOS – What Is in a Name?
The question “PCOS / PMOS – What Is in a Name?” reflects an important change in how this condition is being described globally. In 2026, Polycystic Ovary Syndrome (PCOS) was renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a multistep international consensus process involving patients, healthcare professionals and professional organisations. The change recognises that the condition is not simply about “polycystic” ovaries or ovarian cysts; it can involve interconnected endocrine, metabolic and ovarian features. The words “polyendocrine,” “metabolic” and “ovarian” were selected to represent this broader, multisystem understanding more accurately. Importantly, the new terminology does not describe a new disease or change the underlying evidence-based clinical recommendations; it reframes the name so that it better reflects the condition as it is understood today. This is what makes the session topic especially relevant: it moves the conversation from a narrow focus on ovarian appearance towards a more complete understanding of hormonal, metabolic, reproductive and long-term health.
Dr. S. Vyjayanthi at the International Conclave
Dr. S. Vyjayanthi brings a specialist reproductive medicine perspective to this conversation. She is Director & Consultant Fertility Specialist at MotherToBe Fertility Centre & Academy, Madhapur, Hyderabad, with specialist training spanning reproductive medicine, reproductive surgery and embryology.
Her qualifications include MD, DGO, DNB, MRCOG, MSc (Embryology, UK) and CCT (UK). She is also a Subspecialist in Reproductive Medicine & Surgery (RCOG, UK).
Her international training includes a Clinical Fellowship in Reproductive Medicine at Leeds Reproductive Medicine Unit, UK, an MSc in Embryology from the University of Leeds, UK, and a Subspecialty Fellowship in Reproductive Medicine & Surgery at St Bartholomew’s Hospital, London, UK.
Alongside her clinical work, Dr. Vyjayanthi serves as President, Telangana Chapter RCOG and is a Managing Committee Member of the PCOS Society of India and the Fertility Preservation Society of India.
These professional roles make her participation particularly relevant to a conclave centred on RCOG members and a discussion involving PCOS/PMOS.
Readers can explore Dr. S. Vyjayanthi’s professional profile and reproductive medicine expertise on the MotherToBe website.
Looking Beyond the Ovaries
One reason conversations around PCOS terminology matter is that patients can experience concerns extending beyond a single reproductive feature. From a fertility perspective, disturbances in ovulation may be an important consideration for some people with PCOS. However, reproductive assessment is individual, and fertility cannot be understood through one diagnosis or symptom alone.
Clinical evaluation may consider menstrual and ovulatory patterns, age, reproductive history, ovarian reserve and other relevant factors before an appropriate care pathway is discussed.
This broader perspective makes the theme “Rethink | Rewire | Rewrite” especially fitting for a conversation about PCOS/PMOS. It encourages specialists to reconsider familiar terminology through the lens of evolving clinical understanding rather than treating the name simply as a label.
Where PCOS and Fertility Care Meet
For people planning pregnancy, PCOS can raise understandable questions about ovulation, conception and available fertility treatments. Not every patient with PCOS will have the same fertility experience, and not everyone will require assisted reproductive treatment.
When fertility support is required, treatment should be guided by individual clinical findings. Depending on the circumstances, a fertility specialist may discuss different approaches, which can include ovulation-related management or assisted reproductive options.
MotherToBe provides further patient information about IUI treatment in Hyderabad and IVF treatment in Hyderabad for people who want to understand these fertility pathways.
The practical takeaway is simple: a diagnosis is one part of the clinical picture. Fertility assessment still needs to be tailored to the individual.
Why Professional Conversations Like This Matter
The words used in medicine matter outside conference halls too. They influence conversations between clinicians, shape how patients make sense of a diagnosis and affect the way health information is communicated.
That is why a session asking “PCOS / PMOS – What Is in a Name?” has significance beyond the terminology itself. The International Conclave provides a platform for specialists to examine the subject through professional discussion and exchange.
For Dr. S. Vyjayanthi, the conclave brings several strands of her professional work into the same room: RCOG, reproductive medicine, PCOS and women’s fertility care. That overlap makes her participation especially relevant to the session.
International Conclave – Event at a Glance
- Event: International Conclave
- Organised by: The Association of Tamil Nadu Members of RCOG
- Theme: Rethink | Rewire | Rewrite
- Topic: PCOS / PMOS – What Is in a Name?
- Speaker: Dr. S. Vyjayanthi
- Venue: Anna Salai, Chennai
- Date shown on the event artwork: 19 September 2026
Rethink the Name. Broaden the Conversation.
The PCOS/PMOS discussion is also part of a wider pattern in medicine. As evidence and clinical understanding evolve, the terminology used to describe a condition may need to evolve with them.
At the International Conclave organised by The Association of Tamil Nadu Members of RCOG, Dr. S. Vyjayanthi brings her background in reproductive medicine, PCOS and fertility care to this evolving discussion.
Her participation connects specialist clinical experience with an important question about how PCOS is understood, described and discussed within women’s health.
Rethink the terminology. Rewire the perspective. Rewrite the conversation around women’s reproductive health.
To learn more about MotherToBe’s fertility services or discuss individual fertility concerns, book a fertility consultation.
